Yongxue Wang
Overview
Explore the profile of Yongxue Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang C, Li Y, Duan K, Zhan T, Chen Z, Wang Y, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2024 Dec;
44(12):2359-2366.
PMID: 39725624
Objectives: To investigate the role of mitochondrial autophagy disorder caused by deletion of E3 ubiquitin ligase Parkin in neuroinflammation in a mouse model of MPTP-induced Parkinson's disease (PD). Methods: Wild-type...
2.
Yang M, Zhang X, Liu Q, Wang Y
Chin Herb Med
. 2024 Nov;
16(4):638-655.
PMID: 39606255
Objective: Qingfei Tongluo Plaster (QFP), an improved Chinese medicine hospital preparation, is an attractive treatment option due to its well clinical efficacy, convenience, economy, and patient compliance in the treatment...
3.
Pan Y, Wang M, Wang P, Wei H, Wei X, Wang D, et al.
Biomater Sci
. 2024 Jul;
12(17):4452-4470.
PMID: 39052032
The aim of this study was to develop a semi-interpenetrating network (IPN) hydrogel system suitable for the oral environment, capable of controlled release of DNase-I and oridonin (ORI), to exert...
4.
Nan W, Wang F, Wang H, Xiao W, Li L, Zhang C, et al.
J Mater Chem B
. 2023 Oct;
11(41):9987-10002.
PMID: 37823264
Treating chronic wounds requires transition from proinflammatory M1 to anti-inflammatory M2 dominant macrophages. Based on the role of tumor extracellular vesicles (tEVs) in regulating the phenotypic switching from M1 to...
5.
Shan Y, Mao B, Jin Y, You Y, Wang Y, Shen K, et al.
Tissue Cell
. 2023 Mar;
82:102072.
PMID: 36934683
Background: Ovarian cancer is the most lethal gynaecological malignancy. Damage specific DNA-binding protein 1 (DDB1) functions in nucleotide-excision repair and has been reported to be involved in cancer development. In...
6.
Chen J, Li Y, Wang H, Li T, Gu Y, Wang W, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230574
(1) The accuracy of patient-derived xenografts (PDXs) in predicting ADP-ribose polymerase inhibitor (PARPi) efficacy in ovarian cancer was tested, novel biomarkers were investigated, and whether PARPis could replace platinum-based chemotherapy...
7.
Yuan Z, Wang J, Wang Y, Feng F, Pan L, Xiang Y, et al.
Front Surg
. 2022 Jul;
9:899329.
PMID: 35903253
Objective: The study aimed to explore the clinical characteristics, treatment, and prognosis of cellular angiofibroma in females. Methods: We performed a retrospective study in patients with vulvovaginal cellular angiofibroma treated...
8.
Wang Y, Yin J, Li Y, Shan Y, Gu Y, Jin Y
Front Oncol
. 2022 Jul;
12:913034.
PMID: 35795058
Objective: To assess the surgical and oncological outcomes of laparoscopic restaging compared with laparotomy for apparent early-stage epithelial ovarian cancer. Methods: A retrospective chart review was undertaken of patients who...
9.
Li H, Hao B, Wang Y, Yu D, Chen Z, Du D, et al.
Clin Respir J
. 2022 Jun;
16(7):513-521.
PMID: 35724965
The aim of this study was to investigate the clinical characteristics of Chlamydia psittaci pneumonia and evaluate the diagnostic value of Metagenomic Next-Generation Sequencing (mNGS). A total of 44 patients...
10.
Wang Y, Wang S, Shi H, Lang J
J Obstet Gynaecol Res
. 2021 Jul;
47(9):3392-3395.
PMID: 34229365
Uterocutaneous fistula is an extremely rare postoperative complication and the most appropriate treatment remains unclear. In this case report, we described uterocutaneous fistula of a 41-year-old woman with persistent purulent...